FT596
FT596-102
Phase 1 small_molecule terminated
Quick answer
FT596 for Diffuse Large B Cell Lymphoma is a Phase 1 program (small_molecule) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Diffuse Large B Cell Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated